Clinical Trial Update: A Clinical Study of of RN1701 Injection in the Treatment of Relapsed/Refractory B-Cell Lymphomas [Phase 1]

View source ↗

Summary

This document provides an update on a Phase 1 clinical study of RN1701 Injection for relapsed/refractory B-cell non-Hodgkin lymphoma. The study is not yet recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Non-hodgkin Lymphoma

Drugs mentioned

• RN1701 Injection

Snippet

Sponsor: YANRU WANG | Conditions: Relapsed/Refractory B-cell Lymphoma | Phase 1 | Status: NOT_YET_RECRUITING